Annual Retained Earnings
-$116.80 M
-$13.42 M-12.98%
31 December 2023
Summary:
Qualigen Therapeutics annual retained earnings is currently -$116.80 million, with the most recent change of -$13.42 million (-12.98%) on 31 December 2023. During the last 3 years, it has fallen by -$49.95 million (-74.73%). QLGN annual retained earnings is now -146.93% below its all-time high of -$47.30 million, reached on 31 March 2020.QLGN Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$122.21 M
-$1.79 M-1.49%
30 September 2024
Summary:
Qualigen Therapeutics quarterly retained earnings is currently -$122.21 million, with the most recent change of -$1.79 million (-1.49%) on 30 September 2024. Over the past year, it has dropped by -$7.85 million (-6.87%). QLGN quarterly retained earnings is now -85.50% below its all-time high of -$65.88 million, reached on 30 June 2020.QLGN Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
QLGN Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -13.0% | -6.9% |
| 3 y3 years | -74.7% | -55.3% |
| 5 y5 years | - | - |
QLGN Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -74.7% | at low | -55.3% | at low |
| 5 y | 5 years | -146.9% | at low | -85.5% | at low |
| alltime | all time | -146.9% | at low | -85.5% | at low |
Qualigen Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$122.21 M(+1.5%) |
| June 2024 | - | -$120.41 M(+1.3%) |
| Mar 2024 | - | -$118.84 M(+1.7%) |
| Dec 2023 | -$116.80 M(+13.0%) | -$116.80 M(+2.1%) |
| Sept 2023 | - | -$114.35 M(+3.3%) |
| June 2023 | - | -$110.70 M(+3.2%) |
| Mar 2023 | - | -$107.23 M(+3.7%) |
| Dec 2022 | -$103.39 M | -$103.39 M(+6.6%) |
| Sept 2022 | - | -$97.01 M(+4.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | -$93.19 M(+4.6%) |
| Mar 2022 | - | -$89.06 M(+5.1%) |
| Dec 2021 | -$84.74 M(+26.8%) | -$84.74 M(+7.7%) |
| Sept 2021 | - | -$78.68 M(+3.8%) |
| June 2021 | - | -$75.83 M(+7.5%) |
| Mar 2021 | - | -$70.52 M(-4.7%) |
| Dec 2020 | -$66.85 M(+41.3%) | - |
| Sept 2020 | - | -$73.99 M(+12.3%) |
| June 2020 | - | -$65.88 M |
| Mar 2020 | -$47.30 M | - |
FAQ
- What is Qualigen Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Qualigen Therapeutics?
- What is Qualigen Therapeutics annual retained earnings year-on-year change?
- What is Qualigen Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Qualigen Therapeutics?
- What is Qualigen Therapeutics quarterly retained earnings year-on-year change?
What is Qualigen Therapeutics annual retained earnings?
The current annual retained earnings of QLGN is -$116.80 M
What is the all time high annual retained earnings for Qualigen Therapeutics?
Qualigen Therapeutics all-time high annual retained earnings is -$47.30 M
What is Qualigen Therapeutics annual retained earnings year-on-year change?
Over the past year, QLGN annual retained earnings has changed by -$13.42 M (-12.98%)
What is Qualigen Therapeutics quarterly retained earnings?
The current quarterly retained earnings of QLGN is -$122.21 M
What is the all time high quarterly retained earnings for Qualigen Therapeutics?
Qualigen Therapeutics all-time high quarterly retained earnings is -$65.88 M
What is Qualigen Therapeutics quarterly retained earnings year-on-year change?
Over the past year, QLGN quarterly retained earnings has changed by -$7.85 M (-6.87%)